Stock Market News for September 17, 2026
606 stories published on Thursday, September 17, 2026.
The day runs on New York time, and each time in the list shows the time zone it is in.
Daily news digest for
AI-generated digest, written by Rhea-AI from the day’s company announcements. How Rhea-AI works. Not financial advice.
Markets and capital moves
Lisata Therapeutics (LSTA) agreed to acquire Marea Therapeutics and arranged a $225 million concurrent private placement, a transformational financing that materially strengthens the balance sheet ahead of integration and clinical development.
Burford Capital (BUR) provided an update on a successful capital raise, reinforcing liquidity and underwriting capacity for its litigation finance book — a direct lever for growth and tender offers that investors will monitor.
GMR Solutions (GMRS) completed a term‑loan refinancing and US$200 million debt repayment, a material deleveraging move that reduces interest burden and improves covenant headroom.
Host Digital Inc. (HCWC) announced a common stock offering, a capital strategy that could dilute near‑term EPS but funds growth initiatives in the cloud‑hosting segment.
Earnings and financials
OFS Credit Company (OCCI) reported third‑fiscal‑quarter results, a routine reporting update that helps investors reassess yield, NAV trends and dividend coverage in the credit closed‑end fund space.
Upexi (UPXI) released fiscal year results for the period ended June 30, 2026, offering fresh data points on revenue trajectory and margin pressure that may guide near‑term analyst revisions.
AI, enterprise software and commercial scale
Datasea (DTSS) said its AI agent digital‑marketing services moved into scaled commercial deployment with five agreements representing up to US$89.4 million in potential annualized service volume, a big‑canvas commercial validation for platform‑driven digital services.
Roundtable (RTB) secured a 10‑year, US$1 billion agreement to bring its AI/DeFi media operating system to global scale — a rare multi‑year contract that could meaningfully accelerate revenue and profitability expectations.
Datacenter optics and AI infrastructure
Coherent (COHR) expanded its pluggable optical line systems portfolio with full C‑band amplification to enable higher‑capacity AI datacenter networks, a product move that addresses bandwidth and latency needs for large model training and hyperscale fabrics. See the announcement.
Defense, sensors and autonomy
MicroVision (MVIS) said its IRIS long‑range LiDAR was selected for advanced autonomous ground‑vehicle defense applications, a design win that can open qualification and production opportunities with prime contractors.
Innoviz Technologies (INVZ) — earlier recognized by the Israel Defense Forces' research directorate for its LiDAR — joins MicroVision in signaling growing investor interest in perception sensors tailored for defense and autonomy programs.
Mobix Labs (MOBX) secured a more than US$1 million threat‑detection sensor order, a near‑term contract that complements other sensor suppliers and shows steady procurement at the sub‑contract level.
Biotech, approvals and clinical progress
Ultragenyx (RARE) announced FDA approval of FAYUVI™, the first‑ever approved gene therapy for Sanfilippo syndrome type A (MPS IIIA). This is a major regulatory and commercial milestone that could reshape valuation and partnering dynamics in rare‑disease gene therapy.
Sol‑Gel Technologies (SLGL) said last patient, last visit in its pivotal Phase 3 trial for SGT‑610 in Gorlin syndrome, clearing the way for upcoming data readouts that will drive regulatory and commercial planning.
Quantum, satellites and advanced tech deployments
Viasat (VSAT) reported that ViaSat‑3 F2 has entered service, expanding capacity across the Americas and supporting broadband growth for enterprise and aviation customers.
Telesat (TSAT) and Orange inaugurated Europe’s first Telesat Lightspeed gateway, a low‑latency LEO milestone that could broaden enterprise and defense use cases for satellite broadband.
Aerospace and transport wins
Elroy Air (COHN) announced Bristow’s reservation of 10 additional early delivery positions for Chaparral aircraft, a commercial endorsement that supports backlog visibility and scale‑up of cargo drone operations.
Government, federal orders and GSA‑type wins
Cemtrex / Vicon (CETX) secured about $2.8 million in orders from a U.S. federal agency, reinforcing recurring government revenue potential for integrated‑vision providers.
Corporate boards, leadership and governance
Pagaya (PGY) added payments veteran Jason Gardner to its board, strengthening fintech expertise as the company hones monetization strategies.
Coincheck Group N.V. (CNCK) announced the resignation of Mr. Oyagi as executive chairperson, a leadership change that may prompt governance review and investor questions about strategic continuity.
BitGo (BTGO) appointed Alex Rozman as chief compliance officer, a compliance hire investors view as important amid heightened regulatory scrutiny in crypto custody.
Loop Industries (LOOP) formed a strategic alternatives committee to maximize shareholder value, a governance step that often precedes sale, restructuring, or other strategic options.
Other notable commercial and disclosure moves
- Nomad Power Solutions (NMAD) filed expanded business and financial disclosure following its merger completion, improving transparency around pro‑forma operations for public investors.
- Primech Holdings (PMEC) won a US$5.78 million three‑year facility services contract, supporting multi‑year revenue visibility.
- Faraday Future (FFAI) reported balance‑sheet improvements and about 552 EAI robots sold with positive product gross margin, metrics that matter for liquidity and product‑market fit.
You can use the feed to follow a portfolio or watchlist, research a company, or catch up on developments around shares you own.
It keeps the day's company news in one place, with the dated archive available when you need an earlier session.
What this page covers
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement






















































































































































































































































































































































































































































































































































































